» Articles » PMID: 38731293

β-Sitosterol Reduces the Content of Triglyceride and Cholesterol in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Zebrafish () Model

Overview
Journal Animals (Basel)
Date 2024 May 11
PMID 38731293
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Non-alcoholic fatty liver disease (NAFLD) is strongly associated with hyperlipidemia, which is closely related to high levels of sugar and fat. β-sitosterol is a natural product with significant hypolipidemic and cholesterol-lowering effects. However, the underlying mechanism of its action on aquatic products is not completely understood.

Methods: A high-fat diet (HFD)-induced NAFLD zebrafish model was successfully established, and the anti-hyperlipidemic effect and potential mechanism of β-sitosterol were studied using oil red O staining, filipin staining, and lipid metabolomics.

Results: β-sitosterol significantly reduced the accumulation of triglyceride, glucose, and cholesterol in the zebrafish model. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that differential lipid molecules in β-sitosterol mainly regulated the lipid metabolism and signal transduction function of the zebrafish model. β-sitosterol mainly affected steroid biosynthesis and steroid hormone biosynthesis in the zebrafish model. Compared with the HFD group, the addition of 500 mg/100 g of β-sitosterol significantly inhibited the expression of and in the zebrafish model by at least 50% and 25%, respectively.

Conclusions: β-sitosterol can reduce lipid accumulation in the zebrafish model of NAFLD by regulating lipid metabolism and signal transduction and inhibiting adipogenesis and lipid storage.

Citing Articles

The mechanism of wen jing tang in the treatment of endometriosis: Insights from network pharmacology and experimental validation.

Hu X, Guo X, Wei D, Yue J, Zhang J, Wang B Heliyon. 2024; 10(21):e39292.

PMID: 39524878 PMC: 11546154. DOI: 10.1016/j.heliyon.2024.e39292.


Carob () Flour as Source of Bioactive Compounds: Production, Characterization and Nutraceutical Value.

Benito-Vazquez I, Garrido-Romero M, Hontoria-Caballo G, Garcia-Garcia C, Diez-Municio M, Moreno F Foods. 2024; 13(19).

PMID: 39410059 PMC: 11475722. DOI: 10.3390/foods13193024.

References
1.
Slatter D, Aldrovandi M, OConnor A, Allen S, Brasher C, Murphy R . Mapping the Human Platelet Lipidome Reveals Cytosolic Phospholipase A2 as a Regulator of Mitochondrial Bioenergetics during Activation. Cell Metab. 2016; 23(5):930-44. PMC: 4873619. DOI: 10.1016/j.cmet.2016.04.001. View

2.
Grinberg L, Dabbah Assadi F, Baum G, Zemel R, Tur-Kaspa R, Shochat C . Beneficial Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease (NAFLD) Progression in the Zebrafish Model. Nutrients. 2023; 15(6). PMC: 10052639. DOI: 10.3390/nu15061362. View

3.
Feng S, Gan L, Yang C, Liu A, Lu W, Shao P . Effects of Stigmasterol and β-Sitosterol on Nonalcoholic Fatty Liver Disease in a Mouse Model: A Lipidomic Analysis. J Agric Food Chem. 2018; 66(13):3417-3425. DOI: 10.1021/acs.jafc.7b06146. View

4.
Garay-Lugo N, Dominguez-Lopez A, Garcia A, Aguilar Barrera E, Lopez M, Gomez Alcala A . n-3 Fatty acids modulate the mRNA expression of the Nlrp3 inflammasome and Mtor in the liver of rats fed with high-fat or high-fat/fructose diets. Immunopharmacol Immunotoxicol. 2016; 38(5):353-63. DOI: 10.1080/08923973.2016.1208221. View

5.
Zhao Y, Cheng X, Lin R . Lipidomics applications for discovering biomarkers of diseases in clinical chemistry. Int Rev Cell Mol Biol. 2014; 313:1-26. DOI: 10.1016/B978-0-12-800177-6.00001-3. View